Patient characteristics
Patient characteristic . | No. (%)* . |
---|---|
Total no. of patients | 42 |
Sex | |
Female | 19 (45) |
Male | 23 (55) |
Age, y | |
Mean | 59 |
Range | 35-82 |
Race | |
African American | 7 (17) |
Asian American | 1 (2) |
Caucasian American | 33 (79) |
Other | 1 (2) |
Diagnoses | |
Acute myeloid leukemia | 5 (12) |
Chronic lymphocytic leukemia | 2 (5) |
Hairy cell leukemia | 1 (2) |
Hodgkin disease | 2 (5) |
Multiple myeloma | 24 (57) |
Myelodysplasia with excess blasts | 1 (2) |
Non-Hodgkin lymphoma | 7 (17) |
Karnofsky performance status | |
100 | 3 (7) |
90-80 | 32 (76) |
70-60 | 7 (17) |
Prior therapy | |
Chemotherapy | 40 (95) |
Median number of regimens | 5 |
Range | 0-14 |
Radiation therapy | 16 (38) |
Marrow or stem cell transplantation | 11 (26) |
Patient characteristic . | No. (%)* . |
---|---|
Total no. of patients | 42 |
Sex | |
Female | 19 (45) |
Male | 23 (55) |
Age, y | |
Mean | 59 |
Range | 35-82 |
Race | |
African American | 7 (17) |
Asian American | 1 (2) |
Caucasian American | 33 (79) |
Other | 1 (2) |
Diagnoses | |
Acute myeloid leukemia | 5 (12) |
Chronic lymphocytic leukemia | 2 (5) |
Hairy cell leukemia | 1 (2) |
Hodgkin disease | 2 (5) |
Multiple myeloma | 24 (57) |
Myelodysplasia with excess blasts | 1 (2) |
Non-Hodgkin lymphoma | 7 (17) |
Karnofsky performance status | |
100 | 3 (7) |
90-80 | 32 (76) |
70-60 | 7 (17) |
Prior therapy | |
Chemotherapy | 40 (95) |
Median number of regimens | 5 |
Range | 0-14 |
Radiation therapy | 16 (38) |
Marrow or stem cell transplantation | 11 (26) |
Values in this column are number of patients, and parenthetical values are percentages, except when indicated otherwise in the row headings.